Custom Antibody Market Analysis, Scope, and Growth by 2028
Custom Antibody Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 409.26 Million |
Market Size by 2028 | US$ 833.71 Million |
Global CAGR (2021 - 2028) | 10.7% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Service
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
By service
- Antibody Development
- Antibody Production and Purification
- Antibody Fragmentation and Labelling
By Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Other Custom Antibodies
By Source
- Mice
- Rabbits
- Others
By Research Area
- Oncology
- Immunology
- Stem Cells
- Infectious Diseases
- Neurobiology
- Cardiovascular Diseases
- Others
By End Users
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- ABCAM
- GenScript
- Rockland Immunochemicals, Inc
- ProMab
- BioLegend, Inc
- Agilent Technologies, Inc
- Cell Signaling Technology, Inc